What stocks will increase price by 40% tomorrow

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking which stocks will increase by 40% tomorrow. First, I need to check the data provided in the references. Looking at the references, there's a query result (Number 1) that lists 10 stocks meeting certain criteria: Closing Price > 5-Day MA, 5-Day MA > 10-Day MA, etc. The stocks include BLKB, PATK, LFUS, RCKY, FDP, TW, SUZ, JHG, HAYW, and VRT. Their last prices and changes are provided. Next, I need to see if any of these stocks have upcoming catalysts. Checking reference Number 6, there are earnings announcements for JHG and PATK on 2025-07-31. Since the current time is 2025-07-31 08:15, these earnings have already been released. Looking at the news articles, Vertiv (VRT) has positive earnings results (Numbers 2, 3, 4) with a price target increase. The stock closed at $144.17 with a target of $151, which is about a 4.7% increase. However, the user is asking for a 40% increase, which is much higher. Other stocks like BLKB and LFUS have high volume ratios, indicating potential short-term momentum. But without specific catalysts like earnings beats or price target increases, it's unlikely they'll jump 40%. The user's profile mentions interest in MAG7, AV, US Tech, and AR/VR. None of the listed stocks in the query are directly related to these sectors. The closest is Vertiv, which is in data center infrastructure, but the price target doesn't support a 40% move. Also, the market context (Number 17, 20) shows meme stocks cooling down, and tech stocks like Meta and Microsoft are in focus. However, the data doesn't mention any immediate catalysts for a 40% surge in these stocks. Considering all this, there's no stock in the provided data that's projected to increase by 40% tomorrow. The analysis should conclude that no stock meets this criterion based on the given data. ``` ### 🚨 **Conclusion** 🚨 Based on the data provided, **no stock is projected to increase by 40% tomorrow (2025-07-31)**. However, **Vertiv Holdings (VRT)** shows strong momentum and upside potential due to recent earnings beats and analyst upgrades. Let’s dive into the analysis: --- ### 📊 **Analysis** 📊 #### 1. **Stocks Meeting Key Criteria** The query identified 10 stocks meeting the following criteria: | Metric | Vertiv (VRT) | Blackbaud (BLKB) | Littelfuse (LFUS) | |----------------------------|----------------|----------------|----------------| | Closing Price > 5-Day MA | ✅ | ✅ | ✅ | | 5-Day MA > 10-Day MA | ✅ | ✅ | ✅ | | 10-Day MA > 20-Day MA | ✅ | ✅ | ✅ | | Volume Ratio > 2 | ✅ (3.17) | ✅ (2.62) | ✅ (2.38) | | Quantitative Recommendation Score | 0.66 | 0.88 | 0.74 | **Key Takeaway**: Vertiv stands out with a **price target increase** to $151 , implying a **4.7% upside** from its last price of $144.17. While this doesn’t meet the 40% threshold, it highlights short-term momentum. --- #### 2. **Upcoming Catalysts** - **Vertiv (VRT)**: Recent Q2 earnings beat with record orders and upgraded guidance . Analysts highlight AI infrastructure growth and market share gains. - **Blackbaud (BLKB)**: High volume ratio (3.17) suggests short-term momentum, but no immediate catalysts. - **Littelfuse (LFUS)**: Strong technical setup (bullish moving averages), but no recent news ties to 40% upside. **Key Takeaway**: Vertiv’s AI-driven growth narrative aligns with your interest in **US Tech** and **Innovation**, but the 40% target is unrealistic based on current data. --- #### 3. **Risks & Market Context** - **High Volatility**: Stocks like Vertiv (VRT) and Blackbaud (BLKB) have shown recent price swings (11.02% and 10.44% changes). - **Market Sentiment**: Meme stock fever is fading, with retail investors shifting focus to Big Tech . --- ### 📉 **Why 40% Is Unlikely** 📉 1. **Data Limitations**: The query results don’t show any stock with a price target or catalyst that justifies a 40% increase. 2. **Market Realities**: A 40% price jump in one day requires **existential** news (e.g., FDA approvals, M&A), which isn’t present in the data. 3. **User Profile Alignment**: Your focus on **AI infrastructure** (VRTX) is supported, but the 40% target is too aggressive. --- ### 🛠️ **Final Takeaway** 🛠️ While **Vertiv (VRT)** shows promise with its AI-driven growth and upgraded guidance, a 40% price increase tomorrow is **highly unlikely**. Monitor **VRTX** for short-term upside but stay cautious. For a tech-focused strategy, keep an eye on **FDA approvals** (e.g., Incyte [INCY]) or **partnership announcements** (e.g., Meta [META]). **Stay vigilant and trade responsibly!** 🚨